Synthesis and Study the Antioxidant Activity of some new Heterocyclic Compounds from chalcone

number: 
3990
إنجليزية
department: 
Degree: 
Author: 
Areej Muataz Haider
Supervisor: 
Dr. Ahmed Abdulrazaq Ahmed (Assist. prof.)
year: 
2017

This work involves the synthesis of different five, six and seven membered heterocyclic rings starting from different chalcone derivatives. This work is divided into five different parts:
First part (Scheme 1, 2):A- This part involves the synthesis of new derivatives of α, β-unsaturated ketones (chalcones) using Claisen Schmidt condensation reaction of different aromatic ketones with different aromatic aldehydes to produce (1, 3-diaryl-2-propen-1-one) [A1 (a-g)]. (Scheme 1)B- The synthesized chalcones [A1 (a-g)] were used as starting materials to synthesize another kind of heterocyclic compounds including five, six and seven membered heterocyclic rings. These new compounds are 2-amino[4-(1-naphthyl)-6(2-naphthyl)]pyrimidine [A2(a-c)],pyrazolines [A5(a-d)],ethyl6-(naphthalen-1-yl)4-(naphthalen-2-yl)-2-oxocyclohex-3-enecarboxylate [A8], [4-(1-naphthyl)-6-(2naphthyl)-2-oxo]pyrimidine [A10], [4-(1-naphthyl)-6-(2-naphthyl)-2thione]pyrimidine [A11], [1-carbothioamidyl-3-(1-naphthyl)-5-(2-naphthyl)]-2pyrazoline [A12], by reacting of one mole of chalcones [A1] with one moles of guanidine hydrochloride, hydrazine hydrate, ethyl aceto acetate, urea, thiourea and thiosemicarbazide respectively (Scheme 2).  C- Some of these synthesized compounds in part (B) were used to synthesize other kinds of heterocyclic compounds derivatives include methyl 5-(naphthalen-1-yl)-3(naphthalen-2-yl)-4,5-dihydro-1H-pyrazole-1-carboxylate [A6]and 5-(naphthalen-1yl)-3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazole-1-carbohydrazide [A7], were synthesized from the reaction of pyrazoline derivative with methyl chloro formate to give compound [A6]. and with hydrazine hydrate to give compound [A7] (Scheme2).D- Also this part involves, the reaction of compound [A8] with hydrazine hydrate,2,4-dinitrophenylhydrazine and 2-aminobenzothiazole to produce compounds [A9(a,b,c)]  (Scheme 2).Second part (Scheme 3):A- This part includes the synthesis of different derivatives of Schiff bases [A3 (a,b)],by the reaction of 2-amino-4,6-Arylpyrimidine [A2 (a-c)] with 2hydroxybenzaldehyde,naphthaldehyde, benzaldehyde, 4-nitrobenzaldehyde,furfural, 4-hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 3-bromobenzaldehyde,4-bromobenzaldehyde and  2-hydroxynaphthaldehyde respectively (Scheme 3).B- This part also includes the synthesis of amide derivatives, by the reaction of 4-(2amino-6-phenylpyrimidin-4-yl)phenol [A2c] with different esters such as ethyl acetate, ethyl chloroformate, ethyl aceto acetate, n-butyl acetate and Di-n-butyl phthalate to produce the compounds [A4(a,b,c,d,e)] (Scheme 3).Third part (Scheme 4):This part includes the synthesis of dihydroquinazoline [A16a], imidazolidine4-one [A16b], oxazepine [A16c], Tetrazoline [A16d] and thiazolidine-4-one [A16e] derivatives derived from the cyclization of Schiff base [A15] which synthesized from 1-naphthaldehyde and 4-aminoantipyrine, then the Schiff base was treatment with 2-amino benzoic acid (anthranilic acid), glycine, phthalic anhydride, sodium azide and 2-mercapto acetic acid respectively (Scheme 4).Fourth part:All the synthesized compounds are determined their physical properties (melting points, colors), (FT-IR) spectroscopy and some of them by (H-NMR)spectroscopy and (CHNS) analysis.Fifth part:The free radical scavenging activities were studied using stable free radical compound 1,1-Diphenyl-2-Picryl-hydrazil (DPPH•) for some of synthesized compounds [A1b, A2b, A3e, A3h, A4a, A5a, A6, A7, A8, A9c, A12, A15, A16b]. The Results  showed  that these compounds has varying activity for the free radical scavenging in different concentrations  (12.5, 25, 50 and 100) µg/ml (80.63%, 27%,37%, 61%, 50.62%, 45.83%, 69%, 75.63%, 38.65%, 56.54%, 41.75%, 23.90%,58%) respectively in 100 µg/ml compared with vitamin C (ascorbic acid), which shows the effectiveness of the scavenging free radicals by 80% at a concentration of 100 µg/ml.